Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients

References

• Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006;107:2099–107.
   PubMed Web of Science ®Google Scholar
• Erba HP. Prognostic factor in elderly patients with AML and the implications for treatment. Hematology Am Soc Hematol Educ Program 2007;2007:420–8.
   Google Scholar
• Li Y, Yin Q, Yang L, Chen S, Geng S, Wu X, et al.. Reduced levels of recent thymic emigrants in acute myeloid leukemia patients. Cancer Immunol Immunother 2009;58:1047–55.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen S, Yang L, Zhou Y, Wu X, Huang M, et al.. Clonal expanded TCR Vβ T cells in patients with APL. Hematology 2005;10:135–9.
   PubMed Web of Science ®Google Scholar
• Rezvany M., Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H. Oligoclonal TCR BV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood 1999;94:1063–9.
   PubMed Web of Science ®Google Scholar
• Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb HJ, Roskrow M. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol 2000;111:817–25.
   PubMed Web of Science ®Google Scholar
• Chen S, Yang L, Chen S, Li Y. TCR ζ chain expression in T cells from patients with CML. Hematology 2009;14:95–100.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhu K, Zha X, Chen S, Yang L, Chen S, et al.. Evolution of T-cell clonality in a patient with Ph-negative acute lymphocytic leukemia occurring after interferon and imatinib therapy for Ph-positive chronic myeloid leukemia. J Hematol Oncol 2010;3:14.
   PubMed Web of Science ®Google Scholar
• Call ME, Wucherpfenning KW. The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol 2005;23:101–25.
   PubMed Web of Science ®Google Scholar
• Clevers H, Alarcon B, Wileman T, Terhorst C. The T cell receptor/CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 1988;6:629–62.
   PubMed Web of Science ®Google Scholar
• Call ME, Pyrdol J, Wucherpfenning KW. Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum. EMBO J 2004;23:2348–57.
   PubMed Web of Science ®Google Scholar
• Arnett KL, Harrison SC, Wiley DC. Crystal structure of a human CD3-epsilon/delta dimmer in complex with a UCHT1 single­chain antibody fragment. Proc Natl Acad Sci USA 2004;101:16268–73.
   PubMed Web of Science ®Google Scholar
• Abraham RT, Weiss A. Jurkat T cells and development of the T-cell receptor signaling paradigm. Nat Rev Immunol 2004;4:301–8.
   PubMed Web of Science ®Google Scholar
• Fischer A, de Saint Basile G, Le Deist F. CD3 deficiens. Curr Opin Allergy Clin Immunol 2005;5:491–5.
   PubMed Web of Science ®Google Scholar
• Liossis SN, Ding XZ, Dennis GJ, Tsokos GC. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 1998;101:1448–57.
   PubMed Web of Science ®Google Scholar
• Solomou EE, Wong S, Visconte V, Gibellini F, Young NS. Decreased TCR zeta-chain expression in T cells from patients with acquired aplastic anaemia. Br J Haematol 2007;138:72–6.
   PubMed Web of Science ®Google Scholar
• Torelli GF, Paolini R, Tatarelli C, Soriani A, Vitale A, Guarini A, et al.. Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia. Br J Haematol 2003;120:201–8.
   PubMed Web of Science ®Google Scholar
• Mozaffari F, Hansson L, Kiaii S, Ju X, Rossmann ED, Rabbani H, et al.. Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage. Br J Haematol 2004;124:315–24.
   PubMed Web of Science ®Google Scholar
• Chen S, Yang L, Lu X, Li B, Chan JY, Cai D, et al.. Gene expression profiling of CD3γ, δ, ϵ and ζ chains in CD4+ and CD8+ T-cells from human umbilical cord blood. Hematology 2010;15:230–5.
   PubMed Web of Science ®Google Scholar
• Stams WA, den Boer ML, Beverloo HB, Meijerink JP, Stigter RL, van Wering ER, et al.. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood 2003;101:2743–7.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen S, Yang L, Li B, Chan JY, Cai D. TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord Blood. Transpl Immunol 2009;20:155–62.
   PubMed Web of Science ®Google Scholar
• Hadden JW. Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol 2003;3:1061–71.
   PubMed Web of Science ®Google Scholar
• Costello RT, Rey J, Fauriat C, Gastaut JA, Olive D. New approaches in the immunotherapy of haematological malignancies. Eur J Haematol 2003;70:333–45.
   PubMed Web of Science ®Google Scholar
• DeJarnette JB, Sommers CL, Huang K, Woodside KJ, Emmons R, Katz K, et al.. Specific requirement for CD3epsilon in T cell development. Proc Natl Acad Sci USA 1998;95:14909–14.
   PubMed Web of Science ®Google Scholar
• Kiaii S, Choudhury A, Mozaffari F, Kimby E, Osterborg A, Mellstedt H. Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease. Med Oncol 2005;22:291–302.
   PubMed Web of Science ®Google Scholar
• Shores EW, Love PE. TCRζ chain in T cell development and selection. Curr Opin Immunol 1997;9:380–9.
   PubMed Web of Science ®Google Scholar
• Dadi HK, Simon AJ, Roifman CM. Effect of CD3δ deficiency on maturation of α/β and γ/δ T-cell lineages in severe combined immunodeficiency. N Engl J Med 2003;349:1821–8.
   PubMed Web of Science ®Google Scholar
• Roifman CM. CD3δ immunodeficiency. Curr Opin Allergy Clin Immunol 2004;4:479–84.
   PubMedGoogle Scholar